Autori: Susnjar S
| Naslov | Updated results of the POSITIVE (Pregnancy Outcome and Safety of Interrupting Therapy for Women with Endocrine Responsive Breast Cancer) trial (Article) |
| Autori | Pagani O ... Susnjar S ... (broj koautora 38) |
| Info | ANNALS OF ONCOLOGY, (2026), vol. 37 br. 9, str. 1230-1241 |
| Projekat | ETOP IBCSG Partners Foundation; Alliance for Clinical Trials in Oncology; Breast International Group (BIG); BIG cooperative groups; National Clinical Trials Network of the US National Cancer Institute; International Breast Cancer Study Group (IBCSG); Frontier Science and Technology Research Foundation; Southern Europe (Frontier Southern Europe); Rising Tide Foundation for Clinical Cancer Research [CCR-15-120, CCR-20-200, CCR-24-150]; Pink Ribbon Switzerland, Swiss Cancer League [KLS-3361-02]; San Salvatore Foundation; Swiss Group for Clinical Cancer Research; Clinical Cancer Research Foundation of Eastern Switzerland; Ms Elisabetta Pavesi; Roche Di-agnostics International; Verein Baerguef, Swiss Cancer Foundation; Schweizer Frauenlauf Bern-all in Switzerland; BIG Against Breast Cancer; Baillet Latour Fund, Nationale loterij/Loterie nationale-all in Belgium; Breast Cancer Research Foundation, United States [BCRF 24-011, BCRF 22-124]; Gateway for Cancer Research [G-15-1900]; Fonda-zione Umberto Veronesi, Italy; CA, Germany; Dutch Cancer Society, The Netherlands [KaWeFis Batch7/7723]; Norwegian Breast Cancer Society and Pink Ribbon-both in Norway; ELGC K.K. and Pink Ring-both in Japan; Mr Yong Seop Lee, Ms Sun Hee Kang, and Korean Breast Cancer Foundation-all in South Korea; National Cancer Institute of the National Institutes of Health (NIH) [Alliance for Clinical Trials in Oncology National Cancer Institute Community Oncology Research Program (NCORP)] [UG1CA189823]; Biorepository resource [U24CA196171]; Eastern Cooperative Oncology Group-American College of Radi-ology Imaging Network [ECOG-ACRIN]; NIH National Cancer Institute [UG1CA189828, CA180863]; SWOG Cancer Research Network receives support from the NIH National Cancer Institute [UG1CA189974, U10CA180888]; NRG Oncology receives support from the NIH National Cancer Institute [U10CA180868]; NCORP [CA189867]; Canadian Cancer Society [707213]; Canada Foundation for Innovation; RETHINK Breast Cancer, Canada; Susan G |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science |
